Shili Xu
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Chemokine receptors and signaling
Papers in
-
- Metabolism, Diabetes, and Cancer 4
-
- Cancer, Hypoxia, and Metabolism 9
- Co-authors
- Nouri Neamati (9 shared papers)Nouri Neamati (7 shared papers)Bikash Debnath (5 shared papers)Fedora Grande (5 shared papers)Daniel Braas (5 shared papers)Thomas G. Graeber (4 shared papers)Antonio Garofalo (4 shared papers)Abigail S. Krall (1 shared paper)
- Journals
- Theranostics (3 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Shili Xu
55 papers receiving 2.3k citations
Shili Xu's Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 472
- Oncology 639
- Cell Biology 343
- Molecular Biology 1.1k
- Immunology 340
Countries citing papers authored by Shili Xu
This map shows the geographic impact of Shili Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shili Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shili Xu more than expected).
Fields of papers citing papers by Shili Xu
This network shows the impact of papers produced by Shili Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shili Xu. The network helps show where Shili Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shili Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor Hit paper breakdown → | 2016 | 377 |
| 2 | 2013 | 216 | |
| 3 | 2013 | 212 | |
| 4 | 2012 | 180 | |
| 5 | 2012 | 174 | |
| 6 | 2022 | 111 | |
| 7 | 2013 | 105 | |
| 8 | 2019 | 87 | |
| 9 | 2020 | 76 | |
| 10 | 2013 | 60 | |
| 11 | 2011 | 54 | |
| 12 | 2012 | 52 | |
| 13 | 2013 | 52 | |
| 14 | 2021 | 52 | |
| 15 | 2018 | 50 | |
| 16 | 2019 | 44 | |
| 17 | 2019 | 39 | |
| 18 | 2013 | 35 | |
| 19 | 2010 | 31 | |
| 20 | 2013 | 31 |
About Shili Xu
Shili Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Cell Biology, having authored 61 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), Electrochemical Analysis and Applications (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Pancreatic function and diabetes (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Conducting polymers and applications (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Nanoporous metals and alloys (3 papers). The work is most often cited by research in Cancer Research (472 citations), Oncology (639 citations), Cell Biology (343 citations), Molecular Biology (1.1k citations) and Immunology (340 citations). Shili Xu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Nouri Neamati, Nouri Neamati, Bikash Debnath, Fedora Grande, Daniel Braas, Thomas G. Graeber, Antonio Garofalo, Abigail S. Krall, Heather R. Christofk and Harvey R. Herschman. Their work appears in journals such as Theranostics, Cancer Research, Molecular Cancer Therapeutics, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.